CARDIFF ONCOLOGY, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
CARDIFF ONCOLOGY, INC. (CRDF) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $3.90 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2026-08-11
- CARDIFF ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2026-06-30 was $1.70M, a 6.25% increase year-over-year.
- CARDIFF ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2026-03-31 was $2.20M, a 4.76% increase year-over-year.
- CARDIFF ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2025-12-31 was $700.00K, a 30.00% decline year-over-year.
- CARDIFF ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2025-09-30 was $700.00K, a 22.22% decline year-over-year.
- CARDIFF ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2025 was $5.10M, a 10.87% increase from fiscal 2024.
- CARDIFF ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2024 was $4.60M, a 4.17% decline from fiscal 2023.
- CARDIFF ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2023 was $4.80M, a 2.13% increase from fiscal 2022.
- CARDIFF ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2022 was $4.70M, a 291.67% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $3.90M 10-Q · filed 2026-08-11 | $4.60M derived: sum of 3 quarters · filed 2026-08-11 | $5.30M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | $2.20M 10-Q · filed 2026-05-14 | $2.90M derived: sum of 2 quarters · filed 2026-05-14 | $3.60M derived: sum of 3 quarters · filed 2026-05-14 | $5.20M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.40M derived: sum of 2 quarters · filed 2026-02-24 | $3.00M derived: sum of 3 quarters · filed 2026-08-11 | $5.10M 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | $700.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.30M derived: sum of 2 quarters · filed 2026-08-11 | $4.40M 10-Q · filed 2025-11-06 | $5.40M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | $1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $3.70M 10-Q · filed 2026-08-11 | $4.70M derived: sum of 3 quarters · filed 2026-08-11 | $5.60M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | $2.10M 10-Q · filed 2026-05-14 | $3.10M derived: sum of 2 quarters · filed 2026-05-14 | $4.00M derived: sum of 3 quarters · filed 2026-05-14 | $5.30M derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.90M derived: sum of 2 quarters · filed 2026-02-24 | $3.20M derived: sum of 3 quarters · filed 2026-02-24 | $4.60M 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | $900.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.20M derived: sum of 2 quarters · filed 2025-11-06 | $3.60M 10-Q · filed 2025-11-06 | $4.40M derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | $1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $2.70M 10-Q · filed 2025-07-29 | $3.50M derived: sum of 3 quarters · filed 2025-07-29 | $4.30M derived: sum of 4 quarters · filed 2025-07-29 | ||||
| 2024-03-31 | $1.40M 10-Q · filed 2025-05-08 | $2.20M derived: sum of 2 quarters · filed 2025-05-08 | $3.00M derived: sum of 3 quarters · filed 2025-05-08 | $4.30M derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $1.60M derived: sum of 2 quarters · filed 2025-02-27 | $2.90M derived: sum of 3 quarters · filed 2025-02-27 | $4.80M 10-K · filed 2025-02-27 | ||||
| 2023-09-30 | $800.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $2.10M derived: sum of 2 quarters · filed 2024-11-07 | $4.00M 10-Q · filed 2024-11-07 | $4.70M derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | $1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $3.20M 10-Q · filed 2024-08-08 | $3.90M derived: sum of 3 quarters · filed 2024-08-08 | $4.90M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $1.90M 10-Q · filed 2024-05-02 | $2.60M derived: sum of 2 quarters · filed 2024-05-02 | $3.60M derived: sum of 3 quarters · filed 2024-05-02 | $6.60M derived: sum of 4 quarters · filed 2024-05-02 | ||||
| 2022-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $1.70M derived: sum of 2 quarters · filed 2024-02-29 | $4.70M derived: sum of 3 quarters · filed 2024-02-29 | $4.70M 10-K · filed 2024-02-29 | ||||
| 2022-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $4.00M derived: sum of 2 quarters · filed 2023-11-02 | $4.00M 10-Q · filed 2023-11-02 | $4.00M derived: sum of 4 quarters · filed 2023-11-02 | ||||
| 2022-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $3.00M 10-Q · filed 2023-08-09 | $3.00M derived: sum of 3 quarters · filed 2023-08-09 | $3.00M derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | $1.00K 10-Q · filed 2023-05-04 | $1.00K derived: sum of 2 quarters · filed 2023-05-04 | $1.00K derived: sum of 3 quarters · filed 2023-05-04 | $1.18M derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $0.00 derived: sum of 2 quarters · filed 2023-03-02 | $1.18M derived: sum of 3 quarters · filed 2023-03-02 | $1.20M 10-K · filed 2023-03-02 | ||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $1.18M derived: sum of 2 quarters · filed 2022-11-03 | $1.20M 10-Q · filed 2022-11-03 | $1.90M derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2021-06-30 | $1.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $1.20M 10-Q · filed 2022-08-04 | $1.90M derived: sum of 3 quarters · filed 2022-08-04 | $1.90M derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | $24.00K 10-Q · filed 2022-05-05 | $24.33K 10-Q · filed 2021-05-06 | $724.00K derived: sum of 2 quarters · filed 2022-05-05 | $724.00K derived: sum of 3 quarters · filed 2022-05-05 | $1.49M derived: sum of 4 quarters · filed 2022-05-05 | |||
| 2020-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $700.00K derived: sum of 2 quarters · filed 2022-02-24 | $1.47M derived: sum of 3 quarters · filed 2022-02-24 | $1.50M 10-K · filed 2022-02-24 | $1.52M 10-K · filed 2021-02-25 | |||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $765.07K derived: sum of 2 quarters · filed 2021-11-04 | $800.00K 10-Q · filed 2021-11-04 | $770.58K 10-Q · filed 2020-11-05 | $864.78K derived: sum of 4 quarters · filed 2021-11-04 | |||
| 2020-06-30 | $765.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $800.00K 10-Q · filed 2021-08-05 | $764.72K 10-Q · filed 2020-08-11 | $864.78K derived: sum of 3 quarters · filed 2021-08-05 | $906.89K derived: sum of 4 quarters · filed 2021-08-05 | |||
| 2020-03-31 | $34.93K 10-Q · filed 2021-05-06 | $99.71K derived: sum of 2 quarters · filed 2021-05-06 | $141.82K derived: sum of 3 quarters · filed 2021-05-06 | $232.60K derived: sum of 4 quarters · filed 2021-05-06 | ||||
| 2019-12-31 | $64.78K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $106.89K derived: sum of 2 quarters · filed 2021-02-25 | $197.67K derived: sum of 3 quarters · filed 2021-02-25 | $386.65K 10-K · filed 2021-02-25 | ||||
| 2019-09-30 | $42.11K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $132.89K derived: sum of 2 quarters · filed 2020-11-05 | $321.87K 10-Q · filed 2020-11-05 | $670.46K derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | $90.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $279.76K 10-Q · filed 2020-08-11 | $628.35K derived: sum of 3 quarters · filed 2020-08-11 | $898.04K derived: sum of 4 quarters · filed 2020-08-11 | ||||
| 2019-03-31 | $188.98K 10-Q · filed 2020-05-07 | $537.58K derived: sum of 2 quarters · filed 2020-05-07 | $807.26K derived: sum of 3 quarters · filed 2020-05-07 | $1.08M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | $348.59K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $618.28K derived: sum of 2 quarters · filed 2020-02-27 | $893.05K derived: sum of 3 quarters · filed 2020-02-27 | $1.86M 10-K · filed 2020-02-27 | ||||
| 2018-09-30 | $269.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $544.46K derived: sum of 2 quarters · filed 2019-11-07 | $1.52M 10-Q · filed 2019-11-07 | $2.13M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | $274.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $1.25M 10-Q · filed 2019-08-08 | $1.86M derived: sum of 3 quarters · filed 2019-08-08 | $2.44M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $971.49K 10-Q · filed 2019-05-07 | $1.59M derived: sum of 2 quarters · filed 2019-05-07 | $2.17M derived: sum of 3 quarters · filed 2019-05-07 | $3.44M derived: sum of 4 quarters · filed 2019-05-07 | ||||
| 2017-12-31 | $613.88K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $1.20M derived: sum of 2 quarters · filed 2019-03-06 | $2.47M derived: sum of 3 quarters · filed 2019-03-06 | $3.99M 10-K · filed 2019-03-06 | ||||
| 2017-09-30 | $581.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $1.85M derived: sum of 2 quarters · filed 2018-11-07 | $3.38M 10-Q · filed 2018-11-07 | $4.22M derived: sum of 4 quarters · filed 2018-11-07 | ||||
| 2017-06-30 | $1.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $2.80M 10-Q · filed 2018-08-03 | $3.64M derived: sum of 3 quarters · filed 2018-08-03 | $4.88M derived: sum of 4 quarters · filed 2018-08-03 | ||||
| 2017-03-31 | $1.53M 10-Q · filed 2018-05-08 | $2.37M derived: sum of 2 quarters · filed 2018-05-08 | $3.61M derived: sum of 3 quarters · filed 2018-05-08 | |||||
| 2016-12-31 | $845.49K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $2.08M derived: sum of 2 quarters · filed 2018-02-26 | $6.26M 10-K · filed 2018-02-26 | |||||
| 2016-09-30 | $1.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $5.42M 10-Q · filed 2017-11-09 | ||||||
| 2016-06-30 | $4.18M 10-Q · filed 2017-08-09 | |||||||
| 2015-12-31 | $2.63M 10-K · filed 2017-03-15 | |||||||
| 2014-12-31 | $1.96M 10-K · filed 2017-03-15 | |||||||
| 2013-12-31 | $1.63M 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |